News ArchivesRead News
New pump may revolutionize Parkinson's disease treatment
Wednesday May 23, 2012
Fox news.com - For the past 12 years, 69-year-old Bob Van Housen has been living with Parkinson’s disease. At first, in order to control his symptoms, Van Housen took a medication called levodopa.
Without the medication, Van Housen could not walk or drive. He also suffered from painful muscle spasms.
“The symptoms progressed worse and it got to the point where it was hard to keep up with,” Van Housen said. “(It was) hard to increase the dosage enough to take care of all the symptoms.”
Van Housen’s condition progressed to the point where he was taking five pills every three hours.
“He was ‘off’ for at least seven hours,” said Van Housen’s wife, Carol. “Seven hours is a long time to not be able to function every day.”
The couple often had to cut their trips together short and limit their social outings outside of the house. Because of the limitations his condition put on the family, Van Housen and his wife searched for a new treatment.
Eventually, they learned about the clinical trial at The Cleveland Clinic, run by Dr. Hubert Fernandez, which utilizes a ‘pump’ to maximize treatment.
“We are utilizing the biggest advantages of levodopa which is its efficacy,” Fernandez said. “But we are trying to deliver it in a way that’s done in a continuous basis so that patients don’t need to take it every hour or every hour and a half.”
The drug comes in a gel form. The gel then flows directly into the small intestine through a pump. The pump is connected to a tube that links inside of the body.
“The small intestine is the largest area in our gastrointestinal system that absorbs the medication,” Fernandez said. “The tube strategically ends there so that maximum absorption of the levodopa occurs.”
The pump used in the trial has various functions, though its ultimate function is to make sure that the patient has a steady flow of the drug, throughout the entire day.
“It looked daunting at first because I’m not a nurse,” Carol Van Housen said. “You have syringes to flush out the tubes. (But) it takes moments –it’s very easy.”
Van Housen said that being part of the trial at Cleveland Clinic has been life-changing. He hopes the treatment is approved by the FDA, so other patients suffering from Parkinson’s can also benefit from it.
"We can predict better how I'm going to feel and how I'm going to act,” Van Housen said. “So we can plan trips and work around those times when I otherwise would have been problematic."
Recent NewsMay 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis
Apr 12 - Obstructive Sleep Apnea Affects Cognition in Parkinson's Disease
Apr 11 - Seattle boxing gym giving hope to Parkinson's patients
Apr 10 - A new rhythm
Apr 10 - Brain cells reprogrammed to make dopamine, with goal of Parkinson's therapy
Apr 6 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
Apr 5 - Combatting the isolation of young onset Parkinson's disease
Apr 1 - The Kid is Alright